Search engine for discovering works of Art, research articles, and books related to Art and Culture
ShareThis
Javascript must be enabled to continue!

Mild Gestational Diabetes and Adverse Pregnancy Outcome: A Systemic Review and Meta-Analysis

View through CrossRef
Background and Objectives: Mild gestational diabetes (GDM) refers to the gestational hyperglycemia, which does not fulfill the diagnostic criteria for GDM. The results of studies on adverse pregnancy outcomes among women with mild GDM are controversial. Therefore, the aim of this systematic review and meta-analysis was to investigate the impact of mild GDM on the risk of adverse maternal and neonatal outcomes.Methods: A thorough literature search was performed to retrieve articles that investigated adverse maternal and neonatal outcomes in women with mild GDM in comparison with non-GDM counterparts. All populations were classified to three groups based on their diagnostic criteria for mild GDM. Heterogeneous and non-heterogeneous results were analyzed using the fixed/random effects models. Publication bias was assessed using the Harbord test. DerSimonian and Laird, and inverse variance methods were used to calculate the pooled relative risk of events. Subgroup analysis was performed based on mild GDM diagnostic criteria. Quality and risk of bias assessment were performed using standard questionnaires.Results: Seventeen studies involving 11,623 pregnant women with mild GDM and 53,057 non-GDM counterparts contributed to the meta-analysis. For adverse maternal outcomes, the results of meta-analysis showed that the women with mild GDM had a significantly higher risk of cesarean section (pooled RR: 1.3, 95% CI 1.2–1.5), pregnancy-induced hypertension (pooled RR: 1.4, 95% CI 1.1–1.7), preeclampsia (pooled RR: 1.3, 95% CI 1.1–1.5) and shoulder dystocia (pooled RR: 2.7, 95% CI 1.5–5.1) in comparison with the non-GDM population. For adverse neonatal outcomes, the pooled relative risk of macrosomia (pooled RR = 0.4, 95% CI: 1.1–1.7), large for gestational age (pooled RR = 1.7, 95% CI: 1.3–2.3), hypoglycemia (pooled RR = 1.6, 95% CI: 1.1–2.3), hyperbilirubinemia (pooled RR = 1.1, 95% CI: 1–1.3), 5 min Apgar <7 (pooled RR = 1.6, 95% CI: 1.1–2.4), admission to the neonatal intensive care unit (pooled RR = 1.5, 95% CI: 1.1–2.1), respiratory distress syndrome (pooled RR = 3.2, 95% CI: 1.8–5.5), and preterm birth (pooled RR = 1.4, 95% CI: 1.1–1.7) was significantly increased in the mild GDM women as compared with the non-GDM population. However, the adverse events of small for gestational age and neonatal death were not significantly different between the groups. Analysis of composite maternal and neonatal outcomes revealed that the risk of those adverse outcomes in the women with mild GDM in all classifications were significantly higher than the non-GDM population. Also, the meta-regression showed that the magnitude of those increased risks in both composite maternal and neonatal outcomes was similar.Conclusion: The risks of sever adverse neonatal outcomes including small for gestational age and neonatal mortality are not increased with mild GDM. However, the increased risks of most adverse maternal and neonatal outcomes are observed. The risks have similar magnitudes for all mild GDM diagnostic classifications.
Title: Mild Gestational Diabetes and Adverse Pregnancy Outcome: A Systemic Review and Meta-Analysis
Description:
Background and Objectives: Mild gestational diabetes (GDM) refers to the gestational hyperglycemia, which does not fulfill the diagnostic criteria for GDM.
The results of studies on adverse pregnancy outcomes among women with mild GDM are controversial.
Therefore, the aim of this systematic review and meta-analysis was to investigate the impact of mild GDM on the risk of adverse maternal and neonatal outcomes.
Methods: A thorough literature search was performed to retrieve articles that investigated adverse maternal and neonatal outcomes in women with mild GDM in comparison with non-GDM counterparts.
All populations were classified to three groups based on their diagnostic criteria for mild GDM.
Heterogeneous and non-heterogeneous results were analyzed using the fixed/random effects models.
Publication bias was assessed using the Harbord test.
DerSimonian and Laird, and inverse variance methods were used to calculate the pooled relative risk of events.
Subgroup analysis was performed based on mild GDM diagnostic criteria.
Quality and risk of bias assessment were performed using standard questionnaires.
Results: Seventeen studies involving 11,623 pregnant women with mild GDM and 53,057 non-GDM counterparts contributed to the meta-analysis.
For adverse maternal outcomes, the results of meta-analysis showed that the women with mild GDM had a significantly higher risk of cesarean section (pooled RR: 1.
3, 95% CI 1.
2–1.
5), pregnancy-induced hypertension (pooled RR: 1.
4, 95% CI 1.
1–1.
7), preeclampsia (pooled RR: 1.
3, 95% CI 1.
1–1.
5) and shoulder dystocia (pooled RR: 2.
7, 95% CI 1.
5–5.
1) in comparison with the non-GDM population.
For adverse neonatal outcomes, the pooled relative risk of macrosomia (pooled RR = 0.
4, 95% CI: 1.
1–1.
7), large for gestational age (pooled RR = 1.
7, 95% CI: 1.
3–2.
3), hypoglycemia (pooled RR = 1.
6, 95% CI: 1.
1–2.
3), hyperbilirubinemia (pooled RR = 1.
1, 95% CI: 1–1.
3), 5 min Apgar <7 (pooled RR = 1.
6, 95% CI: 1.
1–2.
4), admission to the neonatal intensive care unit (pooled RR = 1.
5, 95% CI: 1.
1–2.
1), respiratory distress syndrome (pooled RR = 3.
2, 95% CI: 1.
8–5.
5), and preterm birth (pooled RR = 1.
4, 95% CI: 1.
1–1.
7) was significantly increased in the mild GDM women as compared with the non-GDM population.
However, the adverse events of small for gestational age and neonatal death were not significantly different between the groups.
Analysis of composite maternal and neonatal outcomes revealed that the risk of those adverse outcomes in the women with mild GDM in all classifications were significantly higher than the non-GDM population.
Also, the meta-regression showed that the magnitude of those increased risks in both composite maternal and neonatal outcomes was similar.
Conclusion: The risks of sever adverse neonatal outcomes including small for gestational age and neonatal mortality are not increased with mild GDM.
However, the increased risks of most adverse maternal and neonatal outcomes are observed.
The risks have similar magnitudes for all mild GDM diagnostic classifications.

Related Results

Playing Pregnancy: The Ludification and Gamification of Expectant Motherhood in Smartphone Apps
Playing Pregnancy: The Ludification and Gamification of Expectant Motherhood in Smartphone Apps
IntroductionLike other forms of embodiment, pregnancy has increasingly become subject to representation and interpretation via digital technologies. Pregnancy and the unborn entity...
Pregnancy and Challenging Transient Anti-GAD65 Positivity: A Case Report with Literature Review
Pregnancy and Challenging Transient Anti-GAD65 Positivity: A Case Report with Literature Review
Abstract Introduction During pregnancy, women may develop blood glucose abnormalities like gestational diabetes mellitus (GDM) or, rarely, type 1 diabetes (T1D), which can lead to ...
Nutrition in pregnancy
Nutrition in pregnancy
SUMMARY INTRODUCTION PHYSIOLOGICAL CHANGES DURING PREGNANCY Changes in body composition and weight gain Changes in blood composition Metabolic changes and adaptive responses K...
Tracing Hematological Shifts in Pregnancy: How Anemia and Thrombocytopenia Evolve Across Trimesters
Tracing Hematological Shifts in Pregnancy: How Anemia and Thrombocytopenia Evolve Across Trimesters
Abstract Introduction Given pregnancy's significant impact on hematological parameters, monitoring these changes across trimesters is crucial. This study aims to evaluate hematolog...
Small Cell Lung Cancer and Tarlatamab: A Meta-Analysis of Clinical Trials
Small Cell Lung Cancer and Tarlatamab: A Meta-Analysis of Clinical Trials
Abstract Introduction Tarlatamab is a Delta-like ligand 3 (DLL3) -directed bispecific T-cell engager recently approved for use in patients with advanced small cell lung cancer (SCL...
Pembrolizumab and Sarcoma: A meta-analysis
Pembrolizumab and Sarcoma: A meta-analysis
Abstract Introduction: Pembrolizumab is a monoclonal antibody that promotes antitumor immunity. This study presents a systematic review and meta-analysis of the efficacy and safety...
Gestational Diabetes as a Predictor of Sexual Dysfunction in Pregnant Women
Gestational Diabetes as a Predictor of Sexual Dysfunction in Pregnant Women
Introduction: Pregnancy is associated with changes in sexual function and perhaps many more sexual problems when accompanied by particular disorders such as gestational diabetes. O...

Back to Top